Korneyev, I.A.,
Alexeeva, T.A.,
Al-Shukri, S.H.,
Bernikov, A.N.,
Erkovich, A.A.,
Kamalov, A.A.,
Kogan, M.I.,
Pavlov, V.N.,
Zhuravlev, V.N.,
Pushkar, D.Y. (2016) in 530 (48.9%) men, consisting of mild and mild to moderate, moderate and
severe ED in 375 (34.6%), 78 (7
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) The immune system is
severely compromised in patients with COVID-19. The representative group of 43
Solnyshkina, O. A.,
Fatkullina, N. B.,
Bulatova, A. Z.,
Kireev, V. N.,
Bilyalov, A. R.,
Akhatov, I. S.,
Pavlov, V. N. (2023) for
several temperature regimes.
The validation of the realized model is confirmed by comparing the numerical
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) are accompanied by inactivation of the von Hippel–Lindau gene (VHL). It is known that VHL is a target for
severalYang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) potent anti-inflammatory efficacy in
several disease models, which could be the potential candidates
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) therapeutic strategies for
several cancers. However, the combination effects of ATO and blue LED on tumor